Anti-PLA2R Positivity Does Not Exclude Malignancy in Membranous Nephropathy: Lessons from the Course After Tumor Treatment

Saide Elif Güllülü Boz, Abdülmecit Yıldız; Anti-PLA2R Positivity Does Not Exclude Malignancy in Membranous Nephropathy: Lessons from the Course After Tumor

Authors

Institutions

Publication Details

Journal
Clinical Kidney Journal
Published
2026-10-07
DOI
https://doi.org/10.1093/ckj/sfag357
Primary Topic
Renal Diseases and Glomerulopathies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Anti-PLA2R Positivity Does Not Exclude Malignancy in Membranous Nephropathy: Lessons from the Course After Tumor Treatment

Hande Aypek, Saide Elif Güllülü Boz
Clinical Kidney Journal
Renal Diseases and Glomerulopathies
article

Anti-PLA2R Positivity Does Not Exclude Malignancy in Membranous Nephropathy: Lessons from the Course After Tumor Treatment

Hande Aypek, Saide Elif Güllülü Boz
article en

Abstract

Saide Elif Güllülü Boz, Abdülmecit Yıldız; Anti-PLA2R Positivity Does Not Exclude Malignancy in Membranous Nephropathy: Lessons from the Course After Tumor

Clinical Kidney Journal
Bursa Uludağ Üni̇versi̇tesi̇ (TR)
Openalex Percentile: Top 12%
Renal Diseases and Glomerulopathies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Anti-PLA2R Positivity Does Not Exclude Malignancy in Membranous Nephropathy: Lessons from the Course After Tumor Treatment — Hande Aypek, Saide Elif Güllülü Boz · Clinical Kidney Journal (2026) | TGRS Research Map | TGRS